Want to find Targeted B2B leads? Slice and dice from over 84 million business prospects across 675+ industries, 400+ technologies, ad spend, and much more. Try it now for FREE!

How it works video / FAQ

VentiRx Pharmaceuticals Inc

-

Company Description: VentiRx is a clinical stage biopharmaceutical company committed to the development and commercialization of novel Toll-like Receptor 8 (TLR8) immunotherapies for the treatment of cancer, respiratory and inflammatory diseases.

1301 2nd Ave Ste 2800 Seattle, WA 98101-3808
http://www.ventirx.com
info@ventirx.com
206-689-2259

Industries: Startups

Technologies: VentiRx Pharmaceuticals Inc is using 4 Technologies.

Employees: We found 0 verified contacts and 7 unverified employees.

Social Media: VentiRx Pharmaceuticals Inc has 5 social media shares and likes.

We have 7 emails for VentiRx Pharmaceuticals Inc.

Social Media

Web Server Technology

Apache
The Apache HTTP Server Project is an initiative to develop and maintain an open-source HTTP server for operating systems such as UNIX and Windows NT.

Frameworks Technology

Adobe Dreamweaver
is a proprietary web development tool developed by Adobe Systems. Dreamweaver was created by Macromedia in 1997,[1] and was maintained by them until Macromedia was acquired by Adobe Systems in 2005.

duplicate Technology

Fonts Technology

Google Font API
The "Inline Google Fonts API CSS" filter reduces the number of requests made by a web page that uses the Google Fonts API by inlining the small loader CSS into the webpage. Note that because the loader CSS is browser-specific, this feature is not currently compatible with downstream caching being on or ModifyCachingHeaders being off.

Unverified Contacts

These are contacts we've discovered through publicly available sources and might be outdated.
Use our PerfectLink™ Contact Finder to verify contacts.

Name
Title
Email
Phone
Tressa Randall
VP Regulatory Affairs
Maura Matthews
Dir Product Development
Kristi Manjarrez
Sr. Dir Clinical Affairs
Tom Swallow
VP Finance
Kathleen Fanning
VP Business Development /Alliance Management
Mona Newkirk
Associate Director Clinical Affairs
James Bryan
Chief Medical Officer

Additional Info and Employees

VentiRx Pharmaceuticals develops novel TLR8 therapeutics for the treatment of cancer, allergy, and respiratory and autoimmune diseases.

Name
Title

Michael J. Kamdar
Co - Founder at VentiRx Pharmaceuticals

Gregory N. Dietsch
VP, Research at VentiRx Pharmaceuticals

James Kyle Bryan
Chief Medical Officer at VentiRx Pharmaceuticals

Kathleen Fanning
VP, Business Development & Alliance Management at VentiRx Pharmaceuticals

Kristi Manjarrez
Senior Director, Clinical Affairs at VentiRx Pharmaceuticals

Maura Ann Matthews
Director, Product Development at VentiRx Pharmaceuticals

Mona Newkirk
Associate Director, Clinical Affairs at VentiRx Pharmaceuticals

Tressa D. Randall
VP, Regulatory Affairs at VentiRx Pharmaceuticals

Tom Swallow
VP, Finance at VentiRx Pharmaceuticals

ventirx.com Emails

Sign up to get full access to all the ventirx.com emails we have.

j***@ventirx.com
r***@ventirx.com
t***@ventirx.com

a***@ventirx.com
n***@ventirx.com
p***@ventirx.com

k***@ventirx.com

Find emails for VentiRx Pharmaceuticals Inc executives, including the Chief Executive Officer, Chief Financial Officer, and Chief Marketing Officer.